{"published":"2024-04-06 17:56:19","author_url":"https://blog.hatena.ne.jp/marfan-info/","title":"\u30de\u30eb\u30d5\u30a1\u30f3\u75c7\u5019\u7fa4\u306e\u85ac\u7269\u7ba1\u7406\u3000\u301cARB\u3068\u03b2\u906e\u65ad\u85ac\u306e\u6bd4\u8f03\u301c","width":"100%","provider_name":"Hatena Blog","blog_url":"https://marfan-info.hatenablog.com/","url":"https://marfan-info.hatenablog.com/entry/2024/04/06/175619","blog_title":"\u6d77\u5916\u30de\u30eb\u30d5\u30a1\u30f3\u60c5\u5831 | Global Marfan Updates","description":"Medical Management of Marfan Syndrome 42:43-44:20 And then, we, then went on to look at trials where they had compared angiotensin receptor blockers with beta blockers. This is a different kind of trial. ARB versus beta blockers head-to-head comparison and this was the Pediatric Heart Network trial \u2026","height":"190","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fmarfan-info.hatenablog.com%2Fentry%2F2024%2F04%2F06%2F175619\" title=\"\u30de\u30eb\u30d5\u30a1\u30f3\u75c7\u5019\u7fa4\u306e\u85ac\u7269\u7ba1\u7406\u3000\u301cARB\u3068\u03b2\u906e\u65ad\u85ac\u306e\u6bd4\u8f03\u301c - \u6d77\u5916\u30de\u30eb\u30d5\u30a1\u30f3\u60c5\u5831 | Global Marfan Updates\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","provider_url":"https://hatena.blog","author_name":"marfan-info","type":"rich","categories":["\u30aa\u30f3\u30e9\u30a4\u30f3\u30bb\u30df\u30ca\u30fc","\u5faa\u74b0\u5668","\u85ac"],"image_url":null,"version":"1.0"}